EDAP TMS S.A. (ADR) 

(Public, NASDAQ:EDAP)   Watch this stock   
Find more results for EDAP
Nov 17, 2009
Q3 2009 Edap TMS Earnings Release
Sep 1, 2009
Q2 2009 Edap TMS Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin -7.95% 6.93%
Operating margin -7.65% -20.40%
EBITD margin - -14.72%
Return on average assets - 3.60%
Return on average equity - 10.08%
Employees 149 -

Address

Parc Activite La Poudrette Lamartine 4/6 Rue du Dauphine
Vaulx-en-Velin, 69120
France
+1-781-2211601 (Phone)
+1-781-2211602 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

EDAP TMS S.A. (ADR) discussed on blogs

Ranking 1100+ Micro Cap Stocks by Upside Potential - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009

EDAP TMS S.A. (ADR) discussions

  View all discussions »

Description

EDAP TMS S.A. (EDAP) is a holding company that develops, produces and markets minimally invasive medical devices, mainly for urological diseases through two divisions: High Intensity Focused Ultrasound (HIFU) Division and Urology Devices and Services (UDS) Division. The Company’s HIFU and UDS divisions operate in Europe, the Americas, Asia and the rest of the world. The HIFU division is engaged in the development, manufacturing and marketing of medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. The UDS division is engaged in the development, marketing, manufacturing and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications.

Officers and directors

Philippe Chauveau
Chairman of the Board
Age: 72
Bio & Compensation - Reuters
Marc Oczachowski
Chief Executive Officer
Age: 37
Bio & Compensation - Reuters
Eric Soyer
Chief Financial Officer
Age: 41
Bio & Compensation - Reuters
Hugues De Bantel
Director
Age: 38
Bio & Compensation - Reuters
Pierre Beysson
Director
Age: 66
Bio & Compensation - Reuters
Argil J. Wheelock M.D.
Director
Age: 61
Bio & Compensation - Reuters
Robrecht L.W. Michiels
Director
Age: 50
Bio & Compensation - Reuters